Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Astaxanthin + ubiquinol is an oral combination nutraceutical formulation containing the carotenoid antioxidant astaxanthin and the reduced, active form of Coenzyme Q10, ubiquinol. Developed and distributed by companies such as Gynogen, this combination is designed to mitigate oxidative stress and support cellular energy production. Astaxanthin acts as a potent quencher of singlet oxygen and free radicals, protecting lipid membranes from peroxidation. Ubiquinol serves as a critical component of the mitochondrial electron transport chain, facilitating ATP synthesis and providing lipid-soluble antioxidant protection. The combination is primarily used to support cardiovascular, neurological, and reproductive health, particularly in the management of male infertility and age-related oxidative damage.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on astaxanthin + ubiquinol.